API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
24
PharmaCompass offers a list of Diatrizoate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diatrizoate Sodium manufacturer or Diatrizoate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diatrizoate Sodium manufacturer or Diatrizoate Sodium supplier.
PharmaCompass also assists you with knowing the Diatrizoate Sodium API Price utilized in the formulation of products. Diatrizoate Sodium API Price is not always fixed or binding as the Diatrizoate Sodium Price is obtained through a variety of data sources. The Diatrizoate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diatrizoate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diatrizoate Sodium, including repackagers and relabelers. The FDA regulates Diatrizoate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diatrizoate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diatrizoate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diatrizoate Sodium supplier is an individual or a company that provides Diatrizoate Sodium active pharmaceutical ingredient (API) or Diatrizoate Sodium finished formulations upon request. The Diatrizoate Sodium suppliers may include Diatrizoate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Diatrizoate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diatrizoate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Diatrizoate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Diatrizoate Sodium DMFs exist exist since differing nations have different regulations, such as Diatrizoate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diatrizoate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Diatrizoate Sodium USDMF includes data on Diatrizoate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diatrizoate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diatrizoate Sodium suppliers with USDMF on PharmaCompass.
A Diatrizoate Sodium written confirmation (Diatrizoate Sodium WC) is an official document issued by a regulatory agency to a Diatrizoate Sodium manufacturer, verifying that the manufacturing facility of a Diatrizoate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diatrizoate Sodium APIs or Diatrizoate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Diatrizoate Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Diatrizoate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diatrizoate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diatrizoate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diatrizoate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diatrizoate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diatrizoate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diatrizoate Sodium suppliers with NDC on PharmaCompass.
Diatrizoate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diatrizoate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diatrizoate Sodium GMP manufacturer or Diatrizoate Sodium GMP API supplier for your needs.
A Diatrizoate Sodium CoA (Certificate of Analysis) is a formal document that attests to Diatrizoate Sodium's compliance with Diatrizoate Sodium specifications and serves as a tool for batch-level quality control.
Diatrizoate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Diatrizoate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diatrizoate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Diatrizoate Sodium EP), Diatrizoate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diatrizoate Sodium USP).